Anbio Biotechnology Payments to Acquire Short-term Investments
Anbio Biotechnology (NNNN) reported Payments to Acquire Short-term Investments of $19.42 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-04-07
| Period end | Payments to Acquire Short-term Investments 12 month |
|---|---|
| 2025-12-31 | $19.42M 20-F · filed 2026-04-07 |
| 2024-12-31 | $35.47M 20-F · filed 2026-04-07 |
| 2023-12-31 | $18.54M 20-F · filed 2026-04-07 |